Cargando…

Clinical decision making in postmastectomy radiotherapy in node negative breast cancer

For decades, postmastectomy radiotherapy (PMRT) has been recommended for node positive [N(+)] breast cancer patients; nevertheless, the beneficial effect of PMRT for treatment of node negative [N(−)] disease remains under discussion. Nowadays, the biology of breast cancer and the risk factors (RFs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barrientos, Rodrigo, Samtani, Suraj, Frelinghuysen, Michael, Sotomayor, Camilo, Gormaz, Juan Guillermo, Burotto, Mauricio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214678/ https://www.ncbi.nlm.nih.gov/pubmed/30483354 http://dx.doi.org/10.3332/ecancer.2018.874

Ejemplares similares

MRI and Targeted Biopsy Essential Tools for an Accurate Diagnosis and Treatment Decision Making in Prostate Cancer
por: Samtani, Suraj, et al.
Publicado: (2021)

The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer
por: Zhang, Lei, et al.
Publicado: (2020)

Breast Cancer Staging: Is TNM Ready to Evolve?
por: Cadiz, Fernando, et al.
Publicado: (2017)

Is Cytoreductive Nephrectomy Still a Standard of Care in Metastatic Renal Cell Carcinoma?
por: Renner, Alex, et al.
Publicado: (2019)

Number of Negative Lymph Nodes Can Predict Survival after Postmastectomy Radiotherapy According to Different Breast Cancer Subtypes
por: Wu, San-Gang, et al.
Publicado: (2015)

Primary Adrenal Insufficiency during Immune Checkpoint Inhibitor Treatment: Case Reports and Review of the Literature
por: Salinas, Carlos, et al.
Publicado: (2020)

Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy
por: Wu, San-Gang, et al.
Publicado: (2014)

Current Landscape of Immunotherapy Trials Involving the Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Axis in Intrathoracic Tumors
por: Kareff, Samuel A., et al.
Publicado: (2021)

Is Postmastectomy Radiotherapy Really Needed in Breast Cancer Patients with Many Positive Axillary Lymph Nodes?
por: Marinko, Tanja, et al.
Publicado: (2018)

Stakeholders’ Perspectives on Postmastectomy Breast Reconstruction: Recognizing Ways to Improve Shared Decision Making
por: Hasak, Jessica M., et al.
Publicado: (2017)

Importance of Shared Decision-Making for Vulnerable Populations: Examples from Postmastectomy Breast Reconstruction
por: Grabinski, Victoria F., et al.
Publicado: (2018)

Impact of AJCC prognostic staging on prognosis and postmastectomy radiotherapy decision-making in hormone receptor-positive and HER2-positive breast cancer
por: Li, Guan-Qiao, et al.
Publicado: (2022)

The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB
por: Liu, Jieqiong, et al.
Publicado: (2015)

Effects of postmastectomy radiotherapy on prognosis in different tumor stages of breast cancer patients with positive axillary lymph nodes
por: Jia, Miao-Miao, et al.
Publicado: (2014)

Real-world impact of postmastectomy radiotherapy in T1–2 breast cancer with one to three positive lymph nodes
por: Li, Feng-Yan, et al.
Publicado: (2020)

Dosimetric Comparison of Postmastectomy Radiotherapy Plans for Synchronous Bilateral Breast Cancer, Including Regional Lymph Node Irradiation
por: Wu, Xiuxiu, et al.
Publicado: (2023)

Non-compliance with a postmastectomy radiotherapy guideline: Decision tree and cause analysis
por: Razavi, Amir R, et al.
Publicado: (2008)

Automated treatment planning of postmastectomy radiotherapy
por: Kisling, Kelly, et al.
Publicado: (2019)

Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer
por: Xia, Lin-Yu, et al.
Publicado: (2022)

Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer
por: Tovanabutra, Chokaew, et al.
Publicado: (2020)

Patterns of postmastectomy radiation therapy in clinically node-positive breast cancer patients with pathologically negative lymph nodes after neoadjuvant chemotherapy
por: SAYAN, Mutlay, et al.
Publicado: (2021)

A Hybrid Conformal Planning Technique with Solitary Dynamic Portal for Postmastectomy Radiotherapy with Regional Nodes
por: Rafic, K. Mohamathu, et al.
Publicado: (2017)

Postmastectomy Radiotherapy for Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Meattini, Icro, et al.
Publicado: (2014)

Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1–3 positive lymph nodes: a retrospective study
por: Chitapanarux, Imjai, et al.
Publicado: (2014)

Local and regional recurrence following mastectomy in breast cancer patients with 1–3 positive nodes: implications for postmastectomy radiotherapy volume
por: Park, Shin-Hyung, et al.
Publicado: (2018)

Prepectoral Implant-Based Breast Reconstruction and Postmastectomy Radiotherapy: Short-Term Outcomes
por: Sigalove, Steven, et al.
Publicado: (2017)

A Comparative Study of Hypofractionated and Conventional Radiotherapy in Postmastectomy Breast Cancer Patients
por: Rastogi, Kartick, et al.
Publicado: (2018)

Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy
por: Oonsiri, Puntiwa, et al.
Publicado: (2022)

Risk of Positive Sentinel Lymph Node After Neoadjuvant Systemic Therapy in Clinically Node-Negative Breast Cancer: Implications for Postmastectomy Radiation Therapy and Immediate Breast Reconstruction
por: Samiei, S., et al.
Publicado: (2019)

Application of thermoplastic elastomer (TPE) bolus in postmastectomy radiotherapy
por: Gong, Pan, et al.
Publicado: (2022)

Effect of postmastectomy radiotherapy on triple-negative breast cancer with T1-2 and 1-3 positive axillary lymph nodes: a population-based study using the SEER 18 database
por: Zhang, Jie, et al.
Publicado: (2019)

No difference in dose distribution in organs at risk in postmastectomy radiotherapy with or without breast implant reconstruction
por: Liljegren, Annelie, et al.
Publicado: (2014)

Two-Stage Prosthetic Breast Reconstruction after Mastectomy with or without Prior Postmastectomy Radiotherapy
por: Lam, Thomas C., et al.
Publicado: (2017)

Conventional Versus Different Hypofractionated Radiotherapy Dosage Schedules in Postmastectomy Advanced Breast Cancer
por: Jain, Neeraj, et al.
Publicado: (2022)

Impact of Breast Reconstruction on Biophysical Parameters of Mammary Skin in Patients Receiving Postmastectomy Radiotherapy for Breast Cancer
por: Kim, Haeyoung, et al.
Publicado: (2021)

Postmastectomy radiotherapy using three different techniques: a retrospective evaluation of the incidental dose distribution in the internal mammary nodes
por: Wang, Wei, et al.
Publicado: (2019)

Postmastectomy Reconstruction in Male Breast Cancer
por: Deldar, Romina, et al.
Publicado: (2022)

Dosimetric assessment of brass mesh bolus for postmastectomy photon radiotherapy
por: Manger, Ryan, et al.
Publicado: (2016)

Which Patients Might Benefit from Postmastectomy Radiotherapy in Breast Cancer Patients with T1-2 Tumor and 1-3 Axillary Lymph Nodes Metastasis?
por: Kong, Moonkyoo, et al.
Publicado: (2013)

Postmastectomy Radiotherapy Improves Disease-Free Survival of High Risk of Locoregional Recurrence Breast Cancer Patients with T1-2 and 1 to 3 Positive Nodes
por: He, Zhen-Yu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d4rkpf5mgahenvc8dj1ul17765